EMA And FDA Co-Operate To Reduce GMP Inspections Burden
This article was originally published in The Pink Sheet Daily
Executive Summary
EMA and FDA are offering to conduct joint GMP inspections for certain manufacturing sites, but pharma has been slow to respond.
You may also be interested in...
FDA Plans To Rely On Non-U.S. Regulators In Global Drug Quality Initiative
FDA restructures its staff as it prepares for new U.S.-EU mutual reliance activities to enhance pharmaceutical quality, but it offers few details on upcoming plans.
FDA Plans To Rely On Non-U.S. Regulators In Global Drug Quality Initiative
FDA restructures its staff as it prepares for new U.S.-EU mutual reliance activities to enhance pharmaceutical quality, but it offers few details on upcoming plans.
FDA Launches Global Rx Quality Initiative With Plans To Rely On Non-U.S. Regulators
Agency restructures staff as it prepares for new U.S.-EU mutual reliance activities to enhance pharmaceutical quality but offers few details on upcoming plans.